PROGYNY, INC.
NEW YORK, NY

Progyny, Inc. is a leading provider of fertility benefits, committed to reducing time to pregnancy and increasing treatment success rates while minimizing overall costs through the integration of advanced science, technology, and exceptional service. Founded in Florida, the company holds its mailing address at 1359 Broadway, New York, with a central focus on innovative fertility solutions. Under the vision articulated by CEO David H. Williams, Progyny seeks to redefine industry standards with comprehensive and inclusive benefits, facilitating individuals' aspirations of parenthood with optimal outcomes. David's extensive experience in healthcare leadership was honed at WebMD, where he drove significant growth. Progyny's Chief Operating Officer, Dr. Karin Hingne, leverages her vast expertise in public health and managed care to expand employer adoption of infertility benefits, ensuring women no longer endure undue hardship in achieving motherhood dreams. Her prior roles include CEO positions at US Imaging and CarePlus Health Plan. Chief Financial and Operating Officer Peter L. Van Horn contributes over a decade's experience in enhancing financial and operational efficiencies, drawing on his successful tenure as CFO at WebMD. Progyny differentiates itself by offering cutting-edge fertility treatments managed with empathy and personalized service, ensuring patients access top-tier medical professionals and treatment methodologies. This commitment to excellence underpins an evolving landscape of fertility benefits coverage and management. As a Florida corporation, Progyny was incorporated on September 28, 2015, with its operations overseen by dedicated officers including Beth Seidenberg, Cheryl Scott, and Fred Cohen, among others. The company continually engages with large employers to integrate its Fertility Benefit into healthcare plans.